Motor neuron degeneration in spinal and Bulbar Muscular Atrophy is a skeletal muscle-driven process: Relevance to therapy development and implications for related motor neuron diseases

References

• Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 2009; 187:761-72; PMID:19951898; http://dx.doi.org/10.1083/jcb.200908164
   PubMed Web of Science ®Google Scholar
• Garden GA, La Spada AR. Intercellular (mis)communication in neurodegenerative disease. Neuron 2012; 73:886-901; PMID:22405200; http://dx.doi.org/10.1016/j.neuron.2012.02.017
   PubMed Web of Science ®Google Scholar
• Boillee S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, Kollias G, Cleveland DW. Onset and progression in inherited ALS determined by motor neurons and microglia. Science 2006; 312:1389-92; PMID:16741123; http://dx.doi.org/10.1126/science.1123511
   PubMed Web of Science ®Google Scholar
• Clement AM, Nguyen MD, Roberts EA, Garcia ML, Boillee S, Rule M, McMahon AP, Doucette W, Siwek D, Ferrante RJ, et al. Wild-type nonneuronal cells extend survival of SOD1 mutant motor neurons in ALS mice. Science 2003; 302:113-7; PMID:14526083; http://dx.doi.org/10.1126/science.1086071
   PubMed Web of Science ®Google Scholar
• Gu X, Li C, Wei W, Lo V, Gong S, Li SH, Iwasato T, Itohara S, Li XJ, Mody I, et al. Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. Neuron 2005; 46:433-44; PMID:15882643; http://dx.doi.org/10.1016/j.neuron.2005.03.025
   PubMed Web of Science ®Google Scholar
• Custer SK, Garden GA, Gill N, Rueb U, Libby RT, Schultz C, Guyenet SJ, Deller T, Westrum LE, Sopher BL, et al. Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport. Nat Neurosci 2006; 9:1302-11; PMID:16936724; http://dx.doi.org/10.1038/nn1750
   PubMed Web of Science ®Google Scholar
• Yazawa I, Giasson BI, Sasaki R, Zhang B, Joyce S, Uryu K, Trojanowski JQ, Lee VM. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration. Neuron 2005; 45:847-59; PMID:15797547; http://dx.doi.org/10.1016/j.neuron.2005.01.032
   PubMed Web of Science ®Google Scholar
• La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991; 352:77-9; PMID:2062380; http://dx.doi.org/10.1038/352077a0
   PubMed Web of Science ®Google Scholar
• Katsuno M, Tanaka F, Adachi H, Banno H, Suzuki K, Watanabe H, Sobue G. Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). Prog Neurobiol 2012; PMID:22609045
   PubMed Web of Science ®Google Scholar
• La Spada AR, Taylor JP. Repeat expansion disease: progress and puzzles in disease pathogenesis. Nat Rev Genet 2010; 11:247-58; PMID:20177426; http://dx.doi.org/10.1038/nrg2748
   PubMed Web of Science ®Google Scholar
• Soraru G, D'Ascenzo C, Polo A, Palmieri A, Baggio L, Vergani L, Gellera C, Moretto G, Pegoraro E, Angelini C. Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J Neurol Sci 2008; 264:100-5; PMID:17854832; http://dx.doi.org/10.1016/j.jns.2007.08.012
   PubMed Web of Science ®Google Scholar
• Monks DA, Johansen JA, Mo K, Rao P, Eagleson B, Yu Z, Lieberman AP, Breedlove SM, Jordan CL. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc Natl Acad Sci U S A 2007; 104:18259-64; PMID:17984063; http://dx.doi.org/10.1073/pnas.0705501104
   PubMed Web of Science ®Google Scholar
• Yu Z, Dadgar N, Albertelli M, Gruis K, Jordan C, Robins DM, Lieberman AP. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest 2006; 116:2663-72; PMID:16981011; http://dx.doi.org/10.1172/JCI28773
   PubMed Web of Science ®Google Scholar
• Cortes CJ, Ling SC, Guo LT, Hung G, Tsunemi T, Ly L, Tokunaga S, Lopez E, Sopher BL, Bennett CF, et al. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron 2014; 82:295-307; PMID:24742458; http://dx.doi.org/10.1016/j.neuron.2014.03.001
   PubMed Web of Science ®Google Scholar
• Palazzolo I, Stack C, Kong L, Musaro A, Adachi H, Katsuno M, Sobue G, Taylor JP, Sumner CJ, Fischbeck KH, et al. Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 2009; 63:316-28; PMID:19679072; http://dx.doi.org/10.1016/j.neuron.2009.07.019
   PubMed Web of Science ®Google Scholar
• Lieberman AP, Yu Z, Murray S, Peralta R, Low A, Guo S, Yu XX, Cortes CJ, Bennett CF, Monia BP, et al. Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep 2014; 7:774-84; PMID:24746732; http://dx.doi.org/10.1016/j.celrep.2014.02.008
   PubMed Web of Science ®Google Scholar
• Kordasiewicz HB, Stanek LM, Wancewicz EV, Mazur C, McAlonis MM, Pytel KA, Artates JW, Weiss A, Cheng SH, Shihabuddin LS, et al. Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis. Neuron 2012; 74:1031-44; PMID:22726834; http://dx.doi.org/10.1016/j.neuron.2012.05.009
   PubMed Web of Science ®Google Scholar
• Sopher BL, Thomas PS, Jr., LaFevre-Bernt MA, Holm IE, Wilke SA, Ware CB, Jin LW, Libby RT, Ellerby LM, La Spada AR. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron 2004; 41:687-99; PMID:15003169; http://dx.doi.org/10.1016/S0896-6273(04)00082-0
   PubMed Web of Science ®Google Scholar
• Katsuno M, Adachi H, Minamiyama M, Waza M, Doi H, Kondo N, Mizoguchi H, Nitta A, Yamada K, Banno H, et al. Disrupted transforming growth factor-beta signaling in spinal and bulbar muscular atrophy. J Neurosci 2010; 30:5702-12; PMID:20410122; http://dx.doi.org/10.1523/JNEUROSCI.0388-10.2010
   PubMed Web of Science ®Google Scholar
• Mo K, Razak Z, Rao P, Yu Z, Adachi H, Katsuno M, Sobue G, Lieberman AP, Westwood JT, Monks DA. Microarray analysis of gene expression by skeletal muscle of three mouse models of Kennedy disease/spinal bulbar muscular atrophy. PLoS One 2010; 5:e12922; PMID:20886071; http://dx.doi.org/10.1371/journal.pone.0012922
   PubMed Web of Science ®Google Scholar
• Bosch-Marce M, Wee CD, Martinez TL, Lipkes CE, Choe DW, Kong L, Van Meerbeke JP, Musaro A, Sumner CJ. Increased IGF-1 in muscle modulates the phenotype of severe SMA mice. Hum Mol Genet 2011; 20:1844-53; PMID:21325354; http://dx.doi.org/10.1093/hmg/ddr067
   PubMed Web of Science ®Google Scholar
• Dobrowolny G, Giacinti C, Pelosi L, Nicoletti C, Winn N, Barberi L, Molinaro M, Rosenthal N, Musaro A. Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J Cell Biol 2005; 168:193-9; PMID:15657392; http://dx.doi.org/10.1083/jcb.200407021
   PubMed Web of Science ®Google Scholar
• Murray LM, Comley LH, Thomson D, Parkinson N, Talbot K, Gillingwater TH. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet 2008; 17:949-62; PMID:18065780; http://dx.doi.org/10.1093/hmg/ddm367
   PubMed Web of Science ®Google Scholar
• Mutsaers CA, Wishart TM, Lamont DJ, Riessland M, Schreml J, Comley LH, Murray LM, Parson SH, Lochmuller H, Wirth B, et al. Reversible molecular pathology of skeletal muscle in spinal muscular atrophy. Hum Mol Genet 2011; 20:4334-44; PMID:21840928; http://dx.doi.org/10.1093/hmg/ddr360
   PubMed Web of Science ®Google Scholar
• Park GH, Maeno-Hikichi Y, Awano T, Landmesser LT, Monani UR. Reduced survival of motor neuron (SMN) protein in motor neuronal progenitors functions cell autonomously to cause spinal muscular atrophy in model mice expressing the human centromeric (SMN2) gene. J Neurosci 2010; 30:12005-19; PMID:20826664; http://dx.doi.org/10.1523/JNEUROSCI.2208-10.2010
   PubMed Web of Science ®Google Scholar
• Hua Y, Sahashi K, Rigo F, Hung G, Horev G, Bennett CF, Krainer AR. Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model. Nature 2011; 478:123-6; PMID:21979052; http://dx.doi.org/10.1038/nature10485
   PubMed Web of Science ®Google Scholar
• Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, Boncompagni S, Belia S, Wannenes F, Nicoletti C, Del Prete Z, et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metabol 2008; 8:425-36; PMID:19046573; http://dx.doi.org/10.1016/j.cmet.2008.09.002
   PubMed Web of Science ®Google Scholar
• Miller TM, Kim SH, Yamanaka K, Hester M, Umapathi P, Arnson H, Rizo L, Mendell JR, Gage FH, Cleveland DW, et al. Gene transfer demonstrates that muscle is not a primary target for non-cell-autonomous toxicity in familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2006; 103:19546-51; PMID:17164329; http://dx.doi.org/10.1073/pnas.0609411103
   PubMed Web of Science ®Google Scholar
• Towne C, Raoul C, Schneider BL, Aebischer P. Systemic AAV6 delivery mediating RNA interference against SOD1: neuromuscular transduction does not alter disease progression in fALS mice. Mol Ther 2008; 16:1018-25; PMID:18414477; http://dx.doi.org/10.1038/mt.2008.73
   PubMed Web of Science ®Google Scholar